Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Corimmun
company
About
Corimmun is a drug development company focused on therapeutics and diagnostics for heart and vascular diseases.
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- €680K
- Industries
- Biotechnology,Health Diagnostics
- Founded date
- Jan 1, 2006
- Operating Status
- Active
Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€680K
Corimmun has raised a total of
€680K
in funding over 2 rounds. Their latest funding was raised on
Jan 22, 2007 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 22, 2007 | Seed | €680K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Corimmun is funded by 1 investors.
Bayern Kapital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Bayern Kapital
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
